Search results
Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised
Pharmaceutical Technology via Yahoo Finance· 2 days agoCircRNA is still in very early days of development, but it is expected to trialled in vaccines,...
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Investopedia· 7 days agoModerna (MRNA) shares lost ground in intraday trading Friday as the biotech’s effort to move beyond...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 3 days agoThis analysis aims to determine whether Moderna's stock is significantly overvalued by examining its current market performance and intrinsic value. Founded in 2010 and going public in December ...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials
Investing.com· 4 days agoThe company has announced positive outcomes from its Phase 1 clinical trial for a bivalent norovirus...
UF Health scientists make breakthrough in possible cancer treatment
The Gainesville Sun· 2 days agoThe vaccine uses mRNA (messenger RNA) technology and lipid nanoparticles, which a news release said...
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
FX Empire via Yahoo Finance· 2 days agoThe past five days have been a rollercoaster for Novavax investors, as the share price of the...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 4 days ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Company News For May 13, 2024
Zacks via Yahoo Finance· 3 days agoNovavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine ...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 3 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 3 days agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022....